Analytical Data
-
基因名
RED
- Application
-
别名
eforRed, red chromoprotein
-
种属
Others
-
表达系统
E. coli
-
标签
His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
EU498726
-
表达区间
M1-A684
-
蛋白长度
Full Length
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The RED (Regenerating Gene Expression in Development) recombinant protein has garnered significant attention in the field of molecular biology and regenerative medicine due to its potential role in cellular regeneration and repair. This protein is part of a larger family of proteins involved in the developmental processes and tissue regeneration across various organisms. Research into RED recombinant proteins aims to understand their mechanisms of action, which may facilitate advancements in therapeutic strategies for tissue injuries, degenerative diseases, and age-related conditions. Studies have shown that RED proteins can influence cellular pathways related to growth, differentiation, and apoptosis, making them important targets for gene therapy and bioengineering applications. The ability to produce RED proteins through recombinant DNA technology provides researchers with the opportunity to manipulate these proteins for experimental purposes, allowing for better understanding of their functions in vivo. As the global population ages and the incidence of chronic injuries and diseases rises, the investigation into RED proteins represents a promising avenue for developing treatments that enhance healing and regeneration, thereby improving the quality of life for individuals suffering from various ailments.
